Medically significant infections are increased in patients with juvenile idiopathic arthritis treated with etanercept. Results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study.

Rebecca Davies, Taunton R Southwood, Lianne Kearsley-Fleet, Mark Lunt, Kimme L Hyrich, British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study (BSPAR-ETN)

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Medically significant infections are increased in patients with juvenile idiopathic arthritis treated with etanercept. Results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study.'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology